American College of Cardiology7d
ACC Practice Made Perfect: Precision Planning: Developing Sub-Specialty Strategies in Action
Welcome to the Cardiovascular (CV) Dyad Leadership Strategic Planning Series! In episode three of four, Ms. Amy Brownell will interview Ms. Corrin McCloskey and Dr. Joseph Goeke on developing a ...
American College of Cardiology7d
Multimodality Imaging in Cardiac Masses: Key Points
The following are key points to remember from a state-of-the-art review on multimodality imaging in the diagnostic work-up of patients with cardiac masses: ...
American College of Cardiology9d
ACCEL Lite: What Aspects of Cardiovascular Care are Most Primed for Disruption with AI?
Patients can benefit from better healthcare access and outcomes by services that are enabled by artificial intelligence (AI). The current state of technology is evolving to now allow diagnosis of ...
American College of Cardiology9d
Feature | Spotlight on Chest Pain: ACC’s Tools to Support Clinicians and Patients
New to this year's Summit, the Chest Pain Solution Room offered participants of the Chest Pain – MI Registry and Chest Pain Center Accreditation the opportunity to interact with each other in a ...
American College of Cardiology8d
TAVR in Younger Patients; Atorvastatin vs. Rosuvastatin; Sedentary Behavior and Blood Pressure
In this week’s View, Dr. Eagle looks at the outcomes of balloon-expandable transcatheter aortic valve replacement (TAVR) in younger patients. He then explores the comparative effectiveness and safety ...
American College of Cardiology9d
Top Four Trials From TCT 2024: EARLY TAVR, TRISCEND II, ECLIPSE, and CLEAR SYNERGY (OASIS 9)
In this special edition of Eagle’s Eye View, Dr. Eagle looks four of the most important trials presented at the recent TCT Conference: 1) EARLY TAVR evaluating TAVR compared to clinical surveillance; ...
American College of Cardiology9d
Secondary MR and Percutaneous Interventions: Key Points
The following are key points to remember from a state-of-the-art review on treatment options for patients with secondary mitral regurgitation (SMR): ...
American College of Cardiology9d
Antithrombotic Therapy in High Bleeding Risk for Noncardiac Interventions: Key Points
Galli M, Gragnano F, Berteotti M, et al., on behalf of the Working Group of Thrombosis of the Italian Society of Cardiology. Citation: Antithrombotic Therapy in High Bleeding Risk Part II: Non-Cardiac ...
American College of Cardiology9d
Younger Patients Undergoing Balloon-Expandable TAVR More Likely to Have Comorbidities, Worse Outcomes at 1-Year
Patients younger than 65 years who received balloon-expandable valve TAVR for severe aortic stenosis during the low-surgical risk era were more likely to have comorbidities and exhibited higher rates ...
American College of Cardiology9d
Chest Pain – MI Registry: What is the Risk of Ventricular Arrythmia After Primary PCI For STEMI?
A small proportion of patients with STEMI treated via primary PCI experienced late ventricular tachycardia (VT) or ventricular fibrillation (VF), occurring one or more days following the procedure, ...
American College of Cardiology9d
Peripheral Matters | Bioresorbable Stents in Below-the-Knee Arterial Disease
Below-the-knee (BTK) arterial disease represents a significant challenge in peripheral artery disease (PAD) management, particularly in patients with chronic limb-threatening ischemia (CLTI). CLTI ...
American College of Cardiology7d
Outcomes After Transseptal MViV Replacement
This observational study reports that transseptal MViV with SAPIEN 3/SAPIEN 3 Ultra was associated with excellent procedural outcomes, low complication rates, significant improvement in valve ...